Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02919670 · OUTCOME

Percent Change in Weight From Baseline to Day 14

A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma · Source last updated 2023-03-16

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
percent change
Interval / dispersion
Full Range
Time frame
baseline and day 14

Analysis population: Only 17 participants met the protocol definition of compliance

Groups in this outcome

Enterade and Standard Supportive Care

* Two 8 oz. bottles of Enterade will be administered daily * Enterade will be given orally from admission until day +14 or until discharge * Standard Supportive Care will be administered according to institution's practice Enterade Standard Supportive Care

Placebo and Standard Supportive Care

* Two 8 oz. bottles of Placebo will be administered daily * Placebo will be given orally from admission until day +14 or until discharge * Standard Supportive Care will be administered according to institution's practice Placebo Standard Supportive Care

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Enterade and Standard Supportive Care49
Placebo and Standard Supportive Care50

Reported measurements

Source class 1
Values in percent change · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Enterade and Standard Supportive Care-2.5Not reported-18.411.6Not reported
Placebo and Standard Supportive Care-2.2Not reported-945.9Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        -18.4
        upper Limit
        11.6
        value
        -2.5
      2. group Id
        OG001
        lower Limit
        -9
        upper Limit
        45.9
        value
        -2.2
denoms
  1. counts
    1. group Id
      OG000
      value
      49
    2. group Id
      OG001
      value
      50
    units
    Participants
dispersion Type
Full Range
groups
  1. description
    * Two 8 oz. bottles of Enterade will be administered daily * Enterade will be given orally from admission until day +14 or until discharge * Standard Supportive Care will be administered according to institution's practice Enterade Standard Supportive Care
    id
    OG000
    title
    Enterade and Standard Supportive Care
  2. description
    * Two 8 oz. bottles of Placebo will be administered daily * Placebo will be given orally from admission until day +14 or until discharge * Standard Supportive Care will be administered according to institution's practice Placebo Standard Supportive Care
    id
    OG001
    title
    Placebo and Standard Supportive Care
param Type
MEDIAN
population Description
Only 17 participants met the protocol definition of compliance
reporting Status
POSTED
time Frame
baseline and day 14
title
Percent Change in Weight From Baseline to Day 14
type
SECONDARY
unit Of Measure
percent change

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice